Table 1.
Study Schedule
Group | Number | Monkey(s) | Adrenaline | vPDT | Imaging Time Points |
---|---|---|---|---|---|
1 | 1 | No. 6681 | — | Baseline | Baseline |
After vPDT weeks 2 and 4 | |||||
2 | 1 | No. 6738 | Day 1 to week 8 | — | Baseline |
After administration of adrenaline weeks 2, 4, 6 and 8 | |||||
3 | 2 | No. 4824 | Day 1 to week 8 | Week 4 | Baseline |
No. 6756 | After administration of adrenaline weeks 2 and 4 | ||||
After vPDT weeks 2 and 4 | |||||
4 | 2 | No. 6177 | Day 1 to week 8 | Week 8 | Baseline |
No. 6181 | After administration of adrenaline weeks 2, 4, 6 and 8 | ||||
After vPDT weeks 2 and 4 |